Vanguard Group’s Syra Health Corp. Class A Common Stock SYRA Stock Holding History

Vanguard Group’s Portfolio SYRA Stock Details SYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-34,247	Closed	-$8.9K	–	4354
2025 Q1	$8.9K	Hold	34,247	–	–	﹤0.01%	4259
2024 Q4	$13.7K	Sell	34,247 -17,728	-34%	-$7.14K	﹤0.01%	4275
2024 Q3	$22K	Buy	51,975 +17,728	+52%	+$18.8K	﹤0.01%	4296
2024 Q2	$46.9K	Hold	34,247	–	–	﹤0.01%	4296
2024 Q1	$47.3K	Buy	+34,247	New	+$55.2K	﹤0.01%	4321

Other funds holding SYRA

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Vanguard Group's SYRA Position: Q2 2025 in Review

Vanguard Group sold out of Syra Health Corp. Class A Common Stock (SYRA) in Q2 2025, closing a stake of 34,247 shares — an estimated $8.9K sold.

Vanguard Group first reported a position in SYRA in Q1 2024 and held it in 5 quarters. The position peaked at $47.3K in Q1 2024. 2 funds tracked by Wall St. Rank hold SYRA as of Q2 2025.

Vanguard Group reported no remaining Syra Health Corp. Class A Common Stock position as of Q2 2025 after selling out during the quarter.
Vanguard Group sold 34,247 Syra Health Corp. Class A Common Stock shares in Q2 2025, an estimated $8.9K.
Vanguard Group first reported a position in Syra Health Corp. Class A Common Stock in Q1 2024 and held it in 5 quarters.
Vanguard Group's Syra Health Corp. Class A Common Stock position peaked at $47.3K in Q1 2024.
2 funds tracked by Wall St. Rank held Syra Health Corp. Class A Common Stock as of Q2 2025.

Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.